PET Imaging Quantifying 68Ga-PSMA-11 Uptake in Metastatic Colorectal Cancer

被引：18
|
作者：
Cuda, Tahleesa J. [1 ,2 ]
Riddell, Andrew D. [1 ,2 ]
Liu, Cheng [1 ,3 ,4 ]
Whitehall, Vicki L. [1 ,4 ]
Borowsky, Jennifer [1 ,2 ,4 ]
Wyld, David K. [1 ,2 ]
Burge, Matthew E. [1 ,2 ]
Ahern, Elizabeth [1 ,2 ,4 ]
Griffin, Alison [4 ]
Lyons, Nicholas J. R. [1 ,2 ]
Rose, Stephen E. [5 ]
Clark, David A. [1 ,2 ]
Stevenson, Andrew R. L. [1 ,2 ]
Hooper, John D. [1 ]
Puttick, Simon [5 ]
Thomas, Paul A. [1 ,2 ,6 ]
机构：
[1] Univ Queensland, Brisbane, Qld, Australia
[2] Metro North Hosp & Hlth Serv, Brisbane, Qld, Australia
[3] Envoi Specialist Pathologists, Herston, Qld, Australia
[4] QIMR Berghofer Med Res Inst, Herston, Qld, Australia
[5] CSIRO, Herston, Qld, Australia
[6] Herston Imaging Res Facil, Herston, Qld, Australia
来源：
JOURNAL OF NUCLEAR MEDICINE | 2020年 / 61卷 / 11期
关键词：
metastatic colorectal cancer; peptide receptor radionuclide therapy; PET; theranostics;
D O I：
10.2967/jnumed.119.233312
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
At diagnosis, 22% of colorectal cancer (CRC) patients have metastases, and 50% later develop metastasis. Peptide receptor radionuclide therapy (PRRT), such as Lu-177-PSMA-617, is used to treat metastatic prostate cancer. Lu-177-PSMA-617 targets prostate-specific membrane antigen (PSMA), a cell-surface protein enriched in prostate cancer and the neovasculature of other solid tumors, including CRC. We performed Ga-68-PSMA-11 PET/CT imaging of 10 patients with metastatic CRC to assess metastasis avidity. Eight patients had lesions lacking avidity, and 2 had solitary metastases exhibiting very low avidity. Despite expression of PSMA in CRC neovasculature, none of the patients exhibited tumor avidity sufficient to be considered for Lu-177-PSMA-617 PRRT.
引用
收藏
页码：1576 / 1579
页数：4
相关论文
共 50 条
  • [21] 68Ga-PSMA-11 PET Angiogenesis Imaging In Metastatic Clear Cell Renal Cancer: Can It Replace 18F-FDG PET?
    Singh, H.
    Aggarwal, P.
    Das, C. K.
    Mavuduru, R.
    Kakkar, N.
    Kumar, R.
    Mittal, B.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2022, 49 (SUPPL 1) : S193 - S193
  • [22] 68Ga-PSMA-11 PET/CT in the evaluation of bone metastases in prostate cancer
    Sachpekidis, C.
    Baeumer, P.
    Hadaschik, B. A.
    Haberkorn, U.
    Dimitrakopoulou-Strauss, A.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2017, 44 : S402 - S403
  • [23] 68Ga-PSMA-11 dynamic PET/CT in the diagnostics of primary prostate cancer
    Sachpekidis, C.
    Eder, M.
    Kopka, K.
    Mier, W.
    Hadaschik, B. A.
    Haberkorn, U.
    Dimitrakopoulou-Strauss, A.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2015, 42 : S669 - S669
  • [24] A Comprehensive Safety Evaluation of 68Ga-PSMA-11 PET/CT in Prostate Cancer
    Nielsen, Julie B.
    Zacho, Helle D.
    Haberkorn, Uwe
    Nielsen, Karin M.
    Dettmann, Katja
    Langkilde, Niels C.
    Petersen, Lars J.
    CLINICAL NUCLEAR MEDICINE, 2017, 42 (07) : 520 - 524
  • [25] Assessment of 68Ga-PSMA-11 PET positivity predictive factors in prostate cancer
    Gutierrez-Cardo, A. L.
    Perez Duarte, A.
    Garcia-Arguello, S. F.
    Lopez Lorenzo, B.
    Lillo Garcia, M. E.
    Valdivielso, P.
    REVISTA ESPANOLA DE MEDICINA NUCLEAR E IMAGEN MOLECULAR, 2019, 38 (01): : 22 - 28
  • [26] 68Ga-PSMA-11 dynamic PET/CT in biochemical relapse of prostate cancer
    Sachpekidis, C.
    Eder, M.
    Kopka, K.
    Mier, W.
    Hadaschik, B. A.
    Dimitrakopoulou-Strauss, A.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2015, 42 : S670 - S670
  • [27] 18F-PSMA-11 as an Attractive 68Ga-PSMA-11 Alternative for Prostate Cancer Imaging
    van Leeuwen, Pim J.
    Emmett, Louise
    EUROPEAN UROLOGY, 2022, 82 (05) : 510 - 511
  • [28] 68Ga-PSMA-11 PET, PCa Recurrence, and Salvage Radiotherapy
    不详
    JOURNAL OF NUCLEAR MEDICINE, 2019, 60 (06) : 25N - 25N
  • [29] The Appearance of Sjogren Syndrome on 68Ga-PSMA-11 PET/CT
    Li, Rou
    Li, Danni
    Li, Xiao
    Zuo, Changjing
    Cheng, Chao
    CLINICAL NUCLEAR MEDICINE, 2021, 46 (06) : 517 - 519
  • [30] 68Ga-PSMA-11 PET imaging in patients with ongoing androgen deprivation therapy for advanced prostate cancer
    Saskia Fassbind
    Daniela A. Ferraro
    Jean-Jacques Stelmes
    Christian D. Fankhauser
    Matthias Guckenberger
    Philipp A. Kaufmann
    Daniel Eberli
    Irene A. Burger
    Benedikt Kranzbühler
    Annals of Nuclear Medicine, 2021, 35 : 1109 - 1116
12345